Produkty 562-34-5

CAS 562-34-5 występuje w naszej ofercie pod nazwami: Chlorogenin/ 99.05% (existing batch purity), Chlorogenin, Chlorogenin, 99.05%. Oferty producentów: TargetMol, GLPBio, Chemat, MedChemExpress. Dostępne opakowania: 1mg, 2mg, 5mg, 10mg, 25mg, 1 mg.

Chlorogenin/ 99.05% (existing batch purity)
TargetMol
  • opakowanie: 1mg, 2mg, 5mg, 10mg
  • Warianty: 5
od 937,32
Zobacz produkt
Chlorogenin
GLPBio, Chemat
  • opakowanie: 1mg, 2mg, 5mg, 10mg
  • Warianty: 6
od 587,60
Zobacz produkt
Chlorogenin, 99.05%
MedChemExpress
  • opakowanie: 1 mg
  • Warianty: 1
od 1629,30
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(1R,2S,4S,5'R,6R,7S,8R,9S,12S,13R,16S,18S,19S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-16,19-diol (CAS 562-34-5) to związek chemiczny o wzorze sumarycznym C27H44O4 i masie molowej 432.6 g/mol. Nazwa systematyczna IUPAC: (1R,2S,4S,5'R,6R,7S,8R,9S,12S,13R,16S,18S,19S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-16,19-diol. InChIKey: PZNPHSFXILSZTM-JUGSJECZSA-N.

Dane identyfikacyjne
Wzór sumarycznyC27H44O4
Masa molowa432.6 g/mol
Nazwa IUPAC(1R,2S,4S,5'R,6R,7S,8R,9S,12S,13R,16S,18S,19S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-16,19-diol
InChIKeyPZNPHSFXILSZTM-JUGSJECZSA-N
SMILESC[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4C[C@@H]([C@@H]6[C@@]5(CC[C@@H](C6)O)C)O)C)C)OC1

Dane obliczone przez PubChem (NCBI)

Synonimy: Chlorogenin, CHLOROGENIN [MI], 5alpha-Spirostan-3beta,6alpha-diol, (25R)-, (25R)-5alpha-spirostan-3beta,6alpha-diol, F-Chlorogenin, orb1296844, (25r)-5a-spirostane-3b,6a-diol
Izomery (ten sam wzór sumaryczny)
trans-(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R,5R)-5,6-dihydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol C27H44O4
(E,6R)-6-[(3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-2-enoic acid C27H44O4
(6R)-6-[(3S,7S,8S,9S,10R,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptanoic acid C27H44O4
trans-(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-5,6-dihydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol C27H44O4
(3aR,6R)-6-(2-carboxyethyl)-3a,6-dimethyl-3-[(2R)-6-methylheptan-2-yl]-2,3,4,5,5a,9,9a,9b-octahydro-1H-cyclopenta[a]naphthalene-7-carboxylic acid C27H44O4
1-O-(8-methylnonyl) 2-O-(7-methyloctyl) benzene-1,2-dicarboxylate C27H44O4
(1R,2S,4S,5'R,6R,7S,8R,9S,12S,13S,15R,16R,18S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-15,16-diol C27H44O4